Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Mental Health Watchdog CCHR Supports New Bill to Help Foster Care Children
  • USA - English


News provided by

Citizens Commission on Human Rights

Mar 23, 2015, 09:00 ET

Share this article

Share toX

Share this article

Share toX


Los Angeles, California (PRWEB) March 23, 2015 -- In a newly released article, the mental health watchdog Citizens Commission on Human Rights (CCHR), applauds newly introduced legislation in the state of California that aims to curb the psychiatric drugging of foster care children. CCHR states that in wake of the recent San Jose Mercury News investigation, “Drugging Our Kids,” which uncovered high rates of psychotropic drugging of California’s foster care children (nearly 25%), lawmakers in California are now understanding the urgency of legislation to curb this practice.[1]

Assembly Bill 1067 will work towards necessary improvements, 'which include making sure our foster children have a say about what medication they are given.' — Assemblyman Mike Gipson (64th District)

Post this

California Assemblyman Mike Gipson (64th District) has submitted language, amending existing legislation (AB 1067), providing for specific protections from psychiatric/medication abuse of children under state care.[2] Supporting groups, such as CCHR, say it is the first legislation to serve foster children rather than psychiatric pharmaceuticals.

CCHR states that Assemblyman Gipson’s legislation would be an important step in changing the system. Specifically, it addresses informed consent issues and rights for minors and non-minors in foster care, including:

  • To be informed of the risks and benefits of psychotropic medication.
  • To appear before the judge determining if psychotropic medication should be administered, with an advocate of his or her choice, and state that he or she objects to any recommendation to prescribe psychotropic medication.
  • The availability to refuse the administration of psychotropic drugs.
  • To have a prescribing doctor disclose any financial ties he or she may have to pharmaceutical companies.[2]

The latter is in response to the revelation by San Jose Mercury News that between 2010-2013 drug makers spent more than $14 million marketing to California doctors treating foster care children and those doctors with high prescription rates typically received the most funding.[3]

CCHR says that a good example of this much needed legislation involves the prescribing of the antipsychotic, Risperdal. Many of the claims surrounding Risperdal involve gynecomastia allegations—a condition that causes young males to grow female breasts. In February 2015, a Philadelphia jury awarded Austin Pledger $2.5 million in damages because he “was not adequately warned” that he would grow size 46DD breasts as a side effect of using the antipsychotic. According to court documents, Pledger was 8 years old when he first was prescribed Risperdal. The court documents also showed that the drug label falsely reported that the risk of gynecomastia was low.[4 - Case No. 120401997, The Court of Common Pleas of Philadelphia County, Filed 4/18/12]

Attorney Allison Folmar is intimately aware of the effects caused by the use of antipsychotics on children. Folmar represented Detroit mother Maryanne Godboldo against state child protective services, not to drug her then 13-year-old daughter with Risperdal, per court documents.[5 - Case No. 11057748-01, 36 District Court, Detroit, Michigan, filed 03/27/2011]

According to Folmar in an interview with CCHR, “Foster children are prescribed psychotropic drugs at rates nearly five times higher than non-foster children. These drugs can cause life-threatening diabetes, violent and suicidal behavior and even brain shrinkage. That is being done to children who already are traumatized…. We need to turn such turmoil into triumph by changing the laws—state-by-state—until every child is protected.”

Bruce Wiseman, the U.S. President of CCHR, states, “In order to do the right thing, to legitimately uphold the mission of the California Department of Social Services, ‘to serve, aid, and protect needy and vulnerable children…,’ support of Assemblyman Gipson’s legislation is a hopeful first step in ebbing the tide of psychiatric prescribing.”[6]

Sign CCHR’s Petition to Prevent the Dangerous Psychotropic Drugging of California’s Foster Care Youth here.

Read the full article here.

About Citizens Commission on Human Rights: CCHR is a non-profit, non-political, non-religious mental health watchdog. Its mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. CCHR has helped to enact more than 150 laws protecting individuals from abusive or coercive mental health practices.

References:

[1] Karen de Sa, "Drugging Our Kids," San Jose Mercury News, 24 Aug. 2014, webspecial.mercurynews.com/druggedkids/?page=pt1.

[2] “An act to amend Section 16001.9 of the Welfare and Institutions Code, relating to foster children,” California Legislative Counsel’s Digest, General Subject: Foster children: psychotropic medication, 16 Feb 2015, cchrint.org/pdfs/leg-counsel-digest-ab-1067.pdf.

[3] Karen de Sa, “Drugging Our Kids: Part III, The Rx Alliance That Drugs Our Kids,” San Jose Mercury News, 23 Nov 2014, webspecial.mercurynews.com/druggedkids/?page=pt3.

[4] Case No. 120401997, The Court of Common Pleas of Philadelphia County, P.P., et al. v. Ortho-McNeil-Janssen Pharmaceuticals, Inc., et al., Filed April 18, 2012; Vinny Vella, “Man, 20, awarded $2.5M in damages after drug gave him breasts,” Philadelphia Daily News, 26 Feb 2015, articles.philly.com/2015-02-26/news/59504751_1_robyn-reed-frenze-risperdal-breasts.

[5] Case No. 11057748-01, 36 District Court, Detroit, Michigan, filed 03/27/2011; Heather Catallo, "Mom who chose to take daughter off medication files lawsuit...," ABC 7, WXYZ Detroit, 10 May 2012, http://www.wxyz.com/news/local-news/investigations/mom-who-chose-to-take-daughter-off-medication-files-lawsuit-alleges-daughter-deprived-of-prosthesis.

[6] “About CDSS,” California Department of Social Services, http://www.cdss.ca.gov/cdssweb/PG190.htm, accessed 19 Mar. 2015.

Media Department, Citizens Commission on Human Rights, http://www.cchrint.org, +1 (323) 467-4242, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.